179 related articles for article (PubMed ID: 15671016)
1. Modification of permeability transition pore arginine(s) by phenylglyoxal derivatives in isolated mitochondria and mammalian cells. Structure-function relationship of arginine ligands.
Johans M; Milanesi E; Franck M; Johans C; Liobikas J; Panagiotaki M; Greci L; Principato G; Kinnunen PK; Bernardi P; Costantini P; Eriksson O
J Biol Chem; 2005 Apr; 280(13):12130-6. PubMed ID: 15671016
[TBL] [Abstract][Full Text] [Related]
2. Ligand-selective modulation of the permeability transition pore by arginine modification. Opposing effects of p-hydroxyphenylglyoxal and phenylglyoxal.
Linder MD; Morkunaite-Haimi S; Kinnunen PK; Bernardi P; Eriksson O
J Biol Chem; 2002 Jan; 277(2):937-42. PubMed ID: 11698400
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the mitochondrial cyclosporin A-sensitive permeability transition pore by the arginine reagent phenylglyoxal.
Eriksson O; Fontaine E; Petronilli V; Bernardi P
FEBS Lett; 1997 Jun; 409(3):361-4. PubMed ID: 9224690
[TBL] [Abstract][Full Text] [Related]
4. Chemical modification of arginines by 2,3-butanedione and phenylglyoxal causes closure of the mitochondrial permeability transition pore.
Eriksson O; Fontaine E; Bernardi P
J Biol Chem; 1998 May; 273(20):12669-74. PubMed ID: 9575230
[TBL] [Abstract][Full Text] [Related]
5. Opening of the mitochondrial permeability transition pore induces reactive oxygen species production at the level of the respiratory chain complex I.
Batandier C; Leverve X; Fontaine E
J Biol Chem; 2004 Apr; 279(17):17197-204. PubMed ID: 14963044
[TBL] [Abstract][Full Text] [Related]
6. Rapid suppression of mitochondrial permeability transition by methylglyoxal. Role of reversible arginine modification.
Speer O; Morkunaite-Haimi S; Liobikas J; Franck M; Hensbo L; Linder MD; Kinnunen PK; Wallimann T; Eriksson O
J Biol Chem; 2003 Sep; 278(37):34757-63. PubMed ID: 12815061
[TBL] [Abstract][Full Text] [Related]
7. Functional consequences of the sustained or transient activation by Bax of the mitochondrial permeability transition pore.
Pastorino JG; Tafani M; Rothman RJ; Marcinkeviciute A; Hoek JB; Farber JL
J Biol Chem; 1999 Oct; 274(44):31734-9. PubMed ID: 10531385
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide and differential effects of ATP on mitochondrial permeability transition.
Piantadosi CA; Tatro LG; Whorton AR
Nitric Oxide; 2002 Feb; 6(1):45-60. PubMed ID: 11829534
[TBL] [Abstract][Full Text] [Related]
9. Tissue-specific differences in Ca
Ricardez-Garcia C; Reyes-Becerril M; Mosqueda-Martinez E; Mendez-Romero O; Ruiz-Ramírez A; Uribe-Carvajal S
Physiol Rep; 2024 May; 12(10):e16056. PubMed ID: 38777811
[TBL] [Abstract][Full Text] [Related]
10. Arginine 107 of yeast ATP synthase subunit g mediates sensitivity of the mitochondrial permeability transition to phenylglyoxal.
Guo L; Carraro M; Sartori G; Minervini G; Eriksson O; Petronilli V; Bernardi P
J Biol Chem; 2018 Sep; 293(38):14632-14645. PubMed ID: 30093404
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the mitochondrial permeability transition by aldehydes.
Irwin WA; Gaspers LD; Thomas JA
Biochem Biophys Res Commun; 2002 Feb; 291(2):215-9. PubMed ID: 11846392
[TBL] [Abstract][Full Text] [Related]
12. The voltage-dependent anion channel is the target for a new class of inhibitors of the mitochondrial permeability transition pore.
Cesura AM; Pinard E; Schubenel R; Goetschy V; Friedlein A; Langen H; Polcic P; Forte MA; Bernardi P; Kemp JA
J Biol Chem; 2003 Dec; 278(50):49812-8. PubMed ID: 12952973
[TBL] [Abstract][Full Text] [Related]
13. Prooxidants open both the mitochondrial permeability transition pore and a low-conductance channel in the inner mitochondrial membrane.
Kushnareva YE; Sokolove PM
Arch Biochem Biophys; 2000 Apr; 376(2):377-88. PubMed ID: 10775426
[TBL] [Abstract][Full Text] [Related]
14. Calcium binding and translocation by the voltage-dependent anion channel: a possible regulatory mechanism in mitochondrial function.
Gincel D; Zaid H; Shoshan-Barmatz V
Biochem J; 2001 Aug; 358(Pt 1):147-55. PubMed ID: 11485562
[TBL] [Abstract][Full Text] [Related]
15. Discrimination between two steps in the mitochondrial permeability transition process.
Ricchelli F; Jori G; Gobbo S; Nikolov P; Petronilli V
Int J Biochem Cell Biol; 2005 Sep; 37(9):1858-68. PubMed ID: 15878839
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial permeability transition is altered in early stages of carcinogenesis of 2-acetylaminofluorene.
Klöhn PC; Bitsch A; Neumann HG
Carcinogenesis; 1998 Jul; 19(7):1185-90. PubMed ID: 9683176
[TBL] [Abstract][Full Text] [Related]
17. In vitro properties of 5-(benzylsulfonyl)-4-bromo-2-methyl-3(2H)-pyridazinone: a novel permeability transition pore inhibitor.
Fuks B; Talaga P; Huart C; Hénichart JP; Bertrand K; Grimée R; Lorent G
Eur J Pharmacol; 2005 Sep; 519(1-2):24-30. PubMed ID: 16099453
[TBL] [Abstract][Full Text] [Related]
18. Benzoquinone inhibits the voltage-dependent induction of the mitochondrial permeability transition caused by redox-cycling naphthoquinones.
Palmeira CM; Wallace KB
Toxicol Appl Pharmacol; 1997 Apr; 143(2):338-47. PubMed ID: 9144450
[TBL] [Abstract][Full Text] [Related]
19. Concentration-dependent effects of nitric oxide on mitochondrial permeability transition and cytochrome c release.
Brookes PS; Salinas EP; Darley-Usmar K; Eiserich JP; Freeman BA; Darley-Usmar VM; Anderson PG
J Biol Chem; 2000 Jul; 275(27):20474-9. PubMed ID: 10791954
[TBL] [Abstract][Full Text] [Related]
20. Induction of the mitochondrial permeability transition by the DNA alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine. Sorting cause and consequence of mitochondrial dysfunction.
Dodoni G; Canton M; Petronilli V; Bernardi P; Di Lisa F
Biochim Biophys Acta; 2004 Jul; 1658(1-2):58-63. PubMed ID: 15282175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
